The US Food and Drug Administration (FDA) has approved a new medication to treat cancer of the bladder and urinary tract.

The US Food and Drug Administration (FDA) has issued a safety announcement about the type 2 diabetes medication pioglitazone.

The US Food and Drug Administration (FDA) has approved Tecentriq (atezolizumab) to treat urothelial carcinoma, the most common type of bladder cancer.

Weighing the benefits of medications against their potential risks is a common conundrum for many doctors. But, for one common diabetes medication, that decision may have gotten a little easier.

Ditching those cigarettes may help more than just your lungs.

Worried about the health effects of the medications you take? There's likely no need to worry about two diabetes medications once thought to increase the risk of cancer.

Smoking is a major cause of lung cancer and has been linked many other cancers. Although survival rates may be improving for smoking-related cancers, survivors may face greater odds of getting a second cancer.

Some cancers respond better to traditional treatments than others. Bladder cancer patients with a certain form of the disease have not always benefited from those treatments.

The kidneys help rid the body of toxins. When the kidneys don’t function properly, it can open the door to other serious diseases, and cancer may be among them.

Patients with deadly bladder cancer usually have surgery. There is additional treatment to improve their survival odds, but it may not be used as often as it should be, new research has shown.